PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Return On Assets in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q2 2024.
  • Provectus Biopharmaceuticals, Inc. Return On Assets for the quarter ending June 30, 2024 was -220 %, a 32.6% decline year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Return On Assets for 2023 was -190 %, a 23.8% decline from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Return On Assets for 2022 was -153 %, a 63% increase from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Return On Assets for 2021 was -414 %, a 28.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -220 -54 -32.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -188 -25.8 -15.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -190 -36.4 -23.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -178 -26.9 -17.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -166 +23 +12.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -162 +105 +39.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -153 +261 +63% Oct 1, 2022 Dec 31, 2022
Q3 2022 -151 +833 +84.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -189 +629 +76.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -267 +307 +53.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -414 +168 +28.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -984 -505 -105% Jul 1, 2021 Sep 30, 2021
Q2 2021 -818 -339 -70.9% Apr 1, 2021 Jun 30, 2021
Q1 2021 -574 -125 -27.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -582 -289 -98.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 -479 -176 -57.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -478 -207 -76.2% Apr 1, 2020 Jun 30, 2020
Q1 2020 -449 -221 -96.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -293 +3.67 +1.24% Oct 1, 2019 Dec 31, 2019
Q3 2019 -303 -24.1 -8.62% Jul 1, 2019 Sep 30, 2019
Q2 2019 -271 +22.3 +7.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -228 +87.1 +27.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -297 +26.6 +8.23% Oct 1, 2018 Dec 31, 2018
Q3 2018 -279 +55 +16.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -294 -5.31 -1.84% Apr 1, 2018 Jun 30, 2018
Q1 2018 -315 -58.2 -22.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -323 -96.8 -42.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -334 -134 -66.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -288 -132 -83.9% Apr 1, 2017 Jun 30, 2017
Q1 2017 -257 -136 -113% Jan 1, 2017 Mar 31, 2017
Q4 2016 -226 -129 -134% Oct 1, 2016 Dec 31, 2016
Q3 2016 -201 -148 -282% Jul 1, 2016 Sep 30, 2016
Q2 2016 -157 -110 -233% Apr 1, 2016 Jun 30, 2016
Q1 2016 -121 -85.9 -246% Jan 1, 2016 Mar 31, 2016
Q4 2015 -97 -51.8 -115% Oct 1, 2015 Dec 31, 2015
Q3 2015 -52.6 +78.3 +59.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -47.1 +103 +68.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -35 +157 +81.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -45.2 +170 +79% Oct 1, 2014 Dec 31, 2014
Q3 2014 -131 +7.57 +5.47% Jul 1, 2014 Sep 30, 2014
Q2 2014 -150 -14.6 -10.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -192 -38.3 -24.9% Jan 1, 2014 Mar 31, 2014
Q4 2013 -215 -63.6 -41.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -138 +1.64 +1.17% Jul 1, 2013 Sep 30, 2013
Q2 2013 -136 +9.99 +6.85% Apr 1, 2013 Jun 30, 2013
Q1 2013 -154 -29.5 -23.8% Jan 1, 2013 Mar 31, 2013
Q4 2012 -152 Oct 1, 2012 Dec 31, 2012
Q3 2012 -140 Jul 1, 2012 Sep 30, 2012
Q2 2012 -146 Apr 1, 2012 Jun 30, 2012
Q1 2012 -124 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.